ChipsThe story, in brief

Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin

Not a pilot. Bristol Myers Squibb just deployed its second NVIDIA SuperPOD—the life sciences industry's largest AI compute cluster.

Paper-cut illustration of an amber microchip with circuit paths extending into a row of data-center cabinets.
The infrastructure powering AI.AI illustration by KeyNews
The KeyNews take

Why it matters

Pharma's AI infrastructure arms race is accelerating. BMS's doubling down on enterprise-scale GPU clusters signals that computational capacity—not just models—is becoming the competitive moat in drug discovery and biotech R&D.

The key facts

5 to know
  1. Bristol Myers Squibb deploying second NVIDIA DGX SuperPOD

  2. Built on NVIDIA Vera Rubin architecture

  3. BMS already runs one of the largest AI clusters in life sciences

  4. Named 'SuperDuperPOD' internally

  5. Infrastructure play in pharma/life sciences sector

Go to the source

NVIDIA Blogblogs.nvidia.com

Publisher excerpt: Erin Davis calls it the “SuperDuperPOD.” That’s two things in one name: pharmaceutical giant Bristol Myers Squibb (BMS) already runs one of the largest AI clusters in life sciences, with serious results to show for it. And they’re doubling down. BMS announced today it is deploying its second NVIDIA…
Read original report
Back to today's editionMore chips news

Keep reading

Related stories

More from Chips